Madrigal Pharmaceuticals, Inc. MDGL Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s net margin?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported net margin of -27.3% in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s net margin changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s net margin increased by 77.9% year-over-year, from -123.4% to -27.3%.
- What does net margin mean?
- The share of every sales dollar that becomes bottom-line profit.
- How do you interpret net margin?
- Higher is better, but net margin mixes operating performance with financing and tax effects and one-off items — read it alongside operating margin to separate the operating story from the rest.
- How does net margin compare across companies?
- Comparable across peers but sensitive to leverage and tax structure; two operationally identical firms can show different net margins purely from financing.